Podcast Beta
Questions and Answers
What primarily causes hemolytic disease of the fetus and newborn (HDFN)?
What percentage of maternal alloimmunization cases is attributed to previous pregnancies?
Which antibodies are primarily responsible for the ABO incompatibility in HDFN?
What was the primary cause of HDFN before the introduction of Rh immune globulin (RhIG)?
Signup and view all the answers
How often do mother and infant present with ABO incompatibility in pregnancies?
Signup and view all the answers
What type of antibodies are primarily found in individuals whose RBCs lack corresponding ABO antigens?
Signup and view all the answers
What is the main risk factor for maternal RBC alloimmunization?
Signup and view all the answers
What class of antibodies are primarily responsible for ABO incompatibility but do not effectively cross the placenta?
Signup and view all the answers
What must be determined if the antibody screen is reactive?
Signup and view all the answers
Which antibodies can be ignored due to their cold-reactive nature?
Signup and view all the answers
What is the outcome when serum is treated with a sulfhydryl reagent?
Signup and view all the answers
Which class of antibodies can anti-M and anti-N be classified as?
Signup and view all the answers
In the context of Rh D-negative patients, when should antibody screening tests be repeated?
Signup and view all the answers
Which type of antibodies are considered common in pregnant women but are not known to cause hemolytic disease of the fetus and newborn (HDFN)?
Signup and view all the answers
What is the effect of unexpected antibody screening in Rh D-negative patients?
Signup and view all the answers
What type of tests are typically employed for screening antibodies in prenatal patients?
Signup and view all the answers
Which group of mothers is most likely to have a clinically significant ABO hemolytic disease of the fetus and newborn (HDFN)?
Signup and view all the answers
What is the typical relationship between ABO antigen development and ABO HDFN severity?
Signup and view all the answers
How does maternal alloimmunization occur?
Signup and view all the answers
What factor increases the risk of fetal-maternal hemorrhage (FMH) during pregnancy?
Signup and view all the answers
What is the percentage of Rh-negative individuals who typically respond by forming anti-D after being transfused with Rh-positive RBCs?
Signup and view all the answers
Which of the following statements about group A2 infants is true?
Signup and view all the answers
What maternal condition is linked to higher production of high-titered IgG ABO antibodies?
Signup and view all the answers
At what stage of pregnancy is the risk of fetal-maternal hemorrhage highest?
Signup and view all the answers
What is the primary reason for RhD-negative maternal sensitization causing severe HDFN?
Signup and view all the answers
How much can the risk of an RhD-negative mother becoming allosensitized be reduced by the appropriate administration of RhIG?
Signup and view all the answers
What is the primary mechanism of action of RhIG?
Signup and view all the answers
When is the first dose of RhIG typically provided to a D-negative mother?
Signup and view all the answers
What should be done if more than 72 hours have passed after the birth of an RhD-positive infant before administering RhIG?
Signup and view all the answers
Why are antibody titers not recommended for determining the effectiveness of RhIG?
Signup and view all the answers
What must be done to distinguish between a woman who has been passively immunized and one who has been actively immunized?
Signup and view all the answers
What is a potential contraindication for administering RhIG?
Signup and view all the answers
What is a primary risk associated with the severing of the fetal to maternal circulation at birth?
Signup and view all the answers
What is the significance of a positive direct antiglobulin test (DAT) in newborns?
Signup and view all the answers
Why can the strength of the DAT reaction be misleading?
Signup and view all the answers
In which scenario is preparing an eluate particularly useful?
Signup and view all the answers
What role does exchange transfusion play in the treatment of hyperbilirubinemia in neonates?
Signup and view all the answers
What is one reason why exchange transfusion is rarely needed today?
Signup and view all the answers
Which of the following statements about infants' blood types is accurate?
Signup and view all the answers
What complication can arise during RhD typing due to maternal antibodies?
Signup and view all the answers
Study Notes
HDFN Overview
- HDFN is a rare condition that results from the destruction of fetal and newborn RBCs by maternal antibodies.
- Maternal antibodies can be either naturally occurring ABO antibodies or develop after exposure to foreign RBCs called alloantibodies.
- Most maternal alloimmunization occurs due to previous pregnancy (83%), while only 4% is due to previous transfusion.
- Before the advent of Rh immune globulin (RhIG), 95% of HDFN cases were caused by maternal antibodies directed against the Rh antigen D.
- Recently, ABO incompatibility has become the most frequent cause of HDFN.
Pathogenesis of HDFN
-
ABO HDFN:
- ABO antibodies are present in the plasma of individuals lacking the corresponding antigen.
- ABO antibodies are predominantly IgM class, which cannot efficiently cross the placenta.
- IgG ABO antibodies can cross the placenta and attach to fetal RBCs.
- Group O individuals are most likely to form high-titer IgG anti-ABO antibodies.
- ABO HDFN is primarily limited to A or B infants of group O mothers with potent anti-A, B antibodies.
- ABO HDFN is often limited to A or B infants of group O mothers.
- Tetanus toxoid administration and helminth parasite infections during pregnancy have been linked to higher IgG ABO antibody levels and severe HDFN.
- The mild course of ABO HDFN is associated with the incomplete development of ABO antigens on fetal RBCs.
- ABO antigens are not fully developed until after the first year of life.
FMH (Fetal-Maternal Hemorrhage)
- Maternal alloimmunization occurs from exposure to foreign RBCs through pregnancy, transfusions, or organ transplants.
- FMH allows spontaneous mixing of fetal and maternal blood during pregnancy.
- The mixing increases throughout pregnancy, with a higher risk in the third trimester.
- Physical disturbances during pregnancy (trauma, abortion, etc.) increase the risk of FMH.
Maternal Factors
- Individuals' ability to produce antibodies varies based on complex genetic factors.
- Rh-negative individuals who receive Rh-positive blood have an 85% chance of developing anti-D antibodies.
Antibody Identification
- If the antibody screen is reactive, the antibody identity must be determined.
- Cold reactive IgM antibodies, such as anti-1, anti-IH, and anti-Lea, are generally not significant.
- Antibodies such as anti-M and anti-N can cause moderate HDFN, although rarely.
- A sulfhydryl reagent can be used to differentiate between IgG and IgM antibodies.
Management of the Infant
- Cord blood testing is important for ABO grouping and RhD typing.
- DAT (Direct Antiglobulin Test) is the primary serologic test for HDFN.
- Elution is sometimes necessary to confirm the cause of HDFN.
- Exchange transfusion is used to replace the neonate's blood and remove bilirubin and maternal antibodies.
- The selection of blood products for the transfusion requires careful consideration of the infant's blood type and potential antigens.
Rh Immune Globulin (RhIG)
- RhIG reduces the risk of alloimmunization in RhD-negative mothers.
- The mechanism of RhIG is unclear but likely involves interfering with B-cell priming to produce anti-D antibodies.
- RhIG doses are given at 28 weeks’ gestation or after trauma, and again after delivery of an RhD-positive infant.
- RhIG offers no benefit if the mother has already formed anti-D antibodies.
- RhIG is not indicated if the infant is D-negative.
- RhIG is recommended for abortions, stillbirths, and ectopic pregnancies, even if fetal blood type cannot be determined.
- Repeated administration of RhIG does not necessarily correlate with effectiveness.
- RhIG is available in IV and intramuscular forms with specific considerations for administration.
- RhIG is contraindicated for individuals with anti-IgA or IgA deficiency and a history of anaphylactic reactions to blood products.
- A maternal sample should be obtained within 1 hour of delivery for screening for massive fetomaternal hemorrhage.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Related Documents
Description
This quiz covers the overview and pathogenesis of Hemolytic Disease of the Fetus and Newborn (HDFN). It delves into the causes and mechanisms of maternal antibody effects on fetal red blood cells, including ABO incompatibility and Rh antigen interactions. Test your knowledge on this rare medical condition!